D‐Cb effectively delivers polo‐like kinase 1 (PLK‐1) antisense oligonucleotides (ASO) to treat glioblastoma in an orthotopic mouse model, demonstrating its potential as a carrier for brain‐targeted gene therapy. The gene discussed is PLK1; the disease is glioblastoma.